Hem › Atopisk dermatit (eksem) › Idaho
Kliniska studier för Atopisk dermatit (eksem) i Idaho
4 studier för Atopisk dermatit (eksem) söker deltagare vid platser i Idaho.
Officiell studietext (engelska)
A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
- Ada West Research - Meridian, Meridian
RekryterarFas 3
Ålder 2 till 11 · Alla kön · Uppdaterad 25 sep. 2026 · NCT06807281A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
- Ada West Research, LLC, Meridian
RekryterarFas 2
Ålder 18 till 65 · Alla kön · Uppdaterad 28 aug. 2026 · NCT07599813A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
- Treasure Valley Medical Research /ID# 266838, Boise
RekryterarFas 3
Ålder 2 till 11 · Alla kön · Uppdaterad 6 aug. 2026 · NCT06461897A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
- Treasure Valley Medical Research /ID# 263738, Boise
RekryterarFas 3
Ålder 18 till 63 · Alla kön · Uppdaterad 6 juli 2026 · NCT06389136Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.